Author

Guanjun Yang

h-index 15 View on Semantic Scholar

We have 3 of 57 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Oxysophocarpine attenuates acute liver injury by targeting FBP1 to suppress ferroptosis and enhance cellular resilience via the PPARα-GPX4 axis.

Acute liver injury (ALI) is a life-threatening clinical condition with limited therapeutic options. Through network pharmacology screening, we identified oxysophocarpine (OSC), a natural compound derived from traditional Chinese medicine, as a potent reactive oxygen species-scavenging agent. In LPS/D-GalN-induced ALI m...

Jin-Jin Shi, Yan-Jun Liu, Ran Wang et al. · Free Radical Biology & Medic... · 0 citations

Open access Sep 2026

Nifuroxazide Pretreatment Protects Against Acute CdCl2 Exposure-Induced Toxicity via Modulating the USP21/AIM2 Inflammasome Axis

Cadmium (Cd) is a ubiquitous environmental pollutant with an exceptionally long biological half-life (10–30 years) and high multi-organ toxicity. While chronic cadmium exposure has been extensively studied, the pathological mechanisms and prophylactic strategies for acute cadmium poisoning remain poorly defined. Here,...

Jing Yu, Feng Xu, Ran Wang et al. · Antioxidants · 0 citations

Review Jul 2026

ZNF207 in human diseases: Molecular mechanisms, signalling networks, and emerging therapeutic opportunities.

Mechanistically, ZNF207 contributes to tumour development and progression through modulation of major oncogenic signalling pathways, including phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin signalling, nuclear factor erythroid 2-related factor 2 (NRF2)-related ferroptosis, spindle checkpoint...

Zhu-Tong Hou, Jia-Rui Chen, Gai-Xia Fang et al. · Biochemical Pharmacology · 0 citations